BDBM106427 US8586579, 16

SMILES CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1

InChI Key InChIKey=KNWOHCMLVYZTJW-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 106427   

Target5-hydroxytryptamine receptor 2A(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106427(US8586579, 16)
Affinity DataKi:  8.5nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2014
Entry Details
US Patent

TargetD(3) dopamine receptor(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106427(US8586579, 16)
Affinity DataKi:  30.6nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106427(US8586579, 16)
Affinity DataKi:  780nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2014
Entry Details
US Patent